Caraway

What is Caraway?

Caraway is the dried fruit of Carum carvi L., an Apiaceae biennial whose fruit carries 3 to 7 percent volatile oil, of which 50 to 65 percent is S-(+)-carvone. The plant grows a rosette in year one and bolts to a flowering stem of 30 to 60 cm in year two, producing crescent-shaped mericarps about 3 mm long with five pale ridges. Those ridges hide oil canals. Crush one fruit and the smell is almost entirely one molecule.

Caraway sits in the same family as fennel, anise, dill, coriander, celery and cumin. It is grown in both biennial and annual forms, the latter Carum carvi var. annuum, with the Netherlands, Finland, Poland, Egypt and Canada among the significant producers. The fruit is what the trade calls a seed, and both terms appear on labels.

Common Names

• Caraway, caraway seed, caraway fruit
• Carvi fructus and Carvi aetheroleum, pharmacopeial Latin for the fruit and the oil
• Meridian fennel, Persian cumin
• Kümmel (German), karawiya (Arabic), shia jeera or vilayati jeera (South Asian)

Primary Active Compounds

• S-(+)-carvone, 50 to 65 percent of the volatile oil and the source of the characteristic odor
• D-limonene, up to 45 percent of the oil, usually the second largest peak by gas chromatography
• Minor monoterpenes including myrcene, trans-dihydrocarvone and carveol, under 3 percent each
• Fixed oil at roughly 10 to 18 percent of the fruit, dominated by petroselinic and linoleic acids

Key Note

Carvone is chiral. Caraway makes the S-(+) form, dextrorotatory and smelling of rye bread. Spearmint makes the R-(-) form, levorotatory and smelling of chewing gum. Same atoms, same connectivity, opposite three-dimensional arrangement, two odors nobody would confuse. This matters commercially, because authentic caraway oil has an optical rotation of roughly +67 to +80 degrees at 20 degrees Celsius and spearmint-derived carvone pulls that number down. It is one of the cheapest authenticity checks in the spice trade and almost never shown to the buyer.

Caraway earns its place in a supplement cabinet on evidence borrowed from a two-ingredient product, which is the whole problem with the category.

Primary Functions & Benefits

Caraway is a carminative and an antispasmodic. Its claims are narrow and the regulatory language is narrower still.

Regulator-recognized use

The European Medicines Agency HMPC adopted two EU herbal monographs on 7 July 2015, EMA/HMPC/715092/2013 for the fruit and EMA/HMPC/715094/2013 for the essential oil. Both grant a single indication: traditional herbal medicinal product for the symptomatic relief of digestive disorders such as bloating and flatulence. Both are traditional-use monographs, not well-established-use monographs, and that distinction is the entire evidence story in two words. Well-established use requires recognized efficacy in the scientific literature. Caraway did not clear that bar in 2015, and the 2020 to 2025 periodic review found no reason to revise either document.

Health Canada’s Natural Health Products monograph on Carum carvi, revised 31 January 2025, permits the same class of statements and no more: traditionally used in herbal medicine to aid digestion, relieve digestive spasms, stimulate appetite, or for flatulent dyspepsia.

What the combination products are for

Functional dyspepsia in both Rome subtypes, postprandial distress and epigastric pain, plus bloating, early satiety and the sensation of pressure, heaviness and fullness after meals. Irritable bowel syndrome sits alongside them with thinner support, mostly from a single 48-patient topical trial.

What caraway does not do

Caraway does not accelerate gastric emptying. Goerg and Spilker tested 90 mg peppermint oil and 50 mg caraway oil against placebo, 10 mg cisapride and 10 mg butylscopolamine in 12 volunteers and found emptying time unchanged. Masuy repeated the question in 2024 in 32 subjects using a 13C breath test, finding no effect at p = 0.54. Whatever caraway is doing, it is not prokinetic.

Forms & Standardization

Whole fruit

Sold as culinary spice. Volatile oil runs 3 to 7 percent by weight and declines with age, heat and surface area. Whole caraway stored closed and dark holds its oil for years. Ground and left open, it loses that oil in months.

Herbal tea, the pharmacopeial preparation

The EMA fruit monograph specifies 0.5 to 2 g of comminuted herbal substance in 150 mL of boiling water, 1 to 3 times daily, giving 1.5 to 6 g of fruit per day at the top of the range. Commission E set the same window decades earlier.

Essential oil

Steam-distilled from the fruit. ISO 8896 puts relative density at 0.900 to 0.920, refractive index at 1.484 to 1.490 and optical rotation at +67 to +80 degrees, all at 20 degrees Celsius, with carvone at 50.0 to 63.0 percent and limonene at 33.0 to 45.0 percent. The European Pharmacopoeia sets carvone at 50 to 65 percent and limonene at 30 to 45 percent. Carvone is the assay marker.

Enteric-coated fixed combination

Enteroplant, and the Menthacarin combination sold as Carmenthin and Gaspan, deliver 90 mg peppermint oil (WS 1340) and 50 mg caraway oil (WS 1520) per capsule, one capsule twice daily. The enteric coat is functional, not cosmetic. Mascher showed in 16 healthy men that coating pushed carvone time-to-peak from 1.3 to 2.5 hours and menthol from 1.7 to 3.0 hours, carrying the oils past the stomach where menthol causes reflux.

Duodenal-release microsphere formulation

COLM-SST, sold in the United States as FDgard, uses 25 mg caraway oil and 20.75 mg L-menthol per capsule, 2 capsules twice daily. That is 100 mg caraway oil per day, the same load as Enteroplant through a different release technology. It launched as a medical food and is currently labeled a dietary supplement carrying the standard statement that the FDA has not evaluated the claims.

Standardization reality

There is no meaningful standardization in the caraway-alone category. Whole-fruit powder capsules typically declare 400 to 500 mg of powder with no carvone specification, no volatile oil minimum and no extraction description. A 500 mg capsule carries roughly 15 to 35 mg of volatile oil if the fruit was fresh and the grinding cold, less if not. Set that beside 50 mg of isolated caraway oil per Enteroplant capsule and the arithmetic explains most of the disappointment.

Food Sources

Caraway is a spice first and a supplement second, so this section carries more weight than usual.

Serving weights

USDA reference weights are 2.1 g for 1 teaspoon of whole caraway seed and 6.7 g for 1 tablespoon. Those two numbers do most of the work here.

Nutrients per teaspoon, 2.1 g

• 7 kcal, 0.4 g protein, 0.3 g fat, 1.1 g carbohydrate
• 0.8 g dietary fiber
• 14 mg calcium, 0.34 mg iron, 5 mg magnesium
• 12 mg phosphorus, 28 mg potassium
• 0.12 mg zinc, 0.027 mg manganese, 0.25 mcg selenium

Per 100 g the whole fruit runs about 333 kcal, 20 g protein, 14.6 g fat, 50 g carbohydrate, 38 g fiber, roughly 690 mg calcium and 16 mg iron. Those figures look impressive and are close to useless, because nobody eats 100 g of caraway. A teaspoon delivers about 1 percent of an adult calcium target and 2 to 4 percent of an iron target. Caraway is not a mineral source in any realistic serving.

Volatile oil per serving, which is the number that matters

Run the arithmetic on the active fraction instead. At 3 to 7 percent volatile oil, 2.1 g of whole caraway holds roughly 63 to 147 mg of oil. At 50 to 65 percent carvone, that is roughly 32 to 96 mg of carvone per teaspoon. One tablespoon at 6.7 g carries roughly 200 to 470 mg of oil and 100 to 300 mg of carvone.

Hold that against the trial dose. Enteroplant delivers 100 mg of caraway oil per day and COLM-SST delivers the same. The EMA oral posology for the essential oil is 0.15 to 0.3 mL daily, roughly 136 to 271 mg. So a single teaspoon of caraway seed is already in the same order of magnitude as a full daily clinical dose, and a tablespoon exceeds it.

Why that arithmetic does not translate

Three reasons, all physical rather than pharmacological.

• The oil is locked in vittae, the resin canals running along the fruit. Swallow a whole caraway fruit and most of it passes intact. Chewing releases some, grinding releases most. The trial capsules contain distilled oil with nothing left to release.
• Nothing protects it from the stomach. Enteroplant and COLM-SST exist because an enteric coat delivers the oil to the duodenum, the site Micklefield identified. Caraway sprinkled on food has no delivery system.
• Cooking and grinding destroy the oil. Ambient spice grinding drives product temperature as high as 90 degrees Celsius. Cryogenic grinding of caraway retains about 32 percent more volatile oil, and temperature-driven quality loss in conventional grinding has been reported at 40 percent for heat-sensitive components. Pre-ground caraway gave up much of its carvone before it reached your kitchen.

Real foods, real content

• Caraway rye bread. If a loaf uses 1 tablespoon of seed and yields 20 slices, each slice carries about 0.34 g of caraway, or roughly 10 to 24 mg of volatile oil. Six slices approximate one teaspoon.
• Sauerkraut and braised cabbage. Typically 1 to 2 teaspoons per kilogram, and much of the oil volatilizes during long cooking.
• Havarti, Leyden and Munster cheeses studded with whole seed, where the fruit stays intact and so does most of the oil.
• Goulash, harissa and Moroccan spice blends, usually under a teaspoon per portion.
• Kümmel and akvavit, where the carvone really is extracted. The alcohol is the larger physiological factor.

Bottom line on food

Eating caraway as food reaches the dose range on paper and almost never in practice. The 1.5 to 6 g per day the EMA describes is achievable in a diet that uses caraway deliberately, as tea or chewed after a meal. Sprinkling it on one dish is not a therapeutic exposure.

Who Should Take Caraway

Caraway is a targeted option with a narrow use case.

Reasonable candidates

• Adults with functional dyspepsia under Rome III or Rome IV, particularly the postprandial distress subtype, who want a non-prescription option and a 4-week trial period. They should use the peppermint plus caraway combination, not caraway alone, because that is where the 580 patients across 5 randomized trials sit.
• Adults with meal-triggered bloating and flatulence without alarm features, for whom the EMA traditional-use indication was written.
• Adults with irritable bowel syndrome who want a low-risk adjunct. Lauche’s 48-patient crossover trial used a topical poultice and reported an IBS-SSS difference of -38.4 at p = 0.033 against the unheated olive oil control, with responder rates of 43.9 percent against 20.0 and 18.9 percent for the controls. Against the heat-matched hot olive oil control the difference was -24.3 at p = 0.139, and the authors concluded the benefit may be a result of the heat application rather than the caraway.
• People already using caraway as a spice who want a structured version of the same exposure, typically a 0.5 to 2 g infusion after meals.

Poor candidates

• Anyone expecting a weight effect from a capsule. The obesity signal comes from 30 mL per day of an aqueous extract in 70 aerobic-trained women over 90 days.
• Anyone with undiagnosed abdominal pain, which needs a workup before it needs a spice.
• Children and adolescents, for reasons covered below.

Who Should AVOID or Use Caution

Contraindications

• Hypersensitivity to caraway or other Apiaceae species. Both EMA monographs name fennel, anise, celery, coriander and dill, and the fruit monograph adds mugwort and birch, reflecting the pollen-food cross-reactivity pattern in this family.
• Children and adolescents under 18 years for oral use of the essential oil, per the aetheroleum monograph, and under 12 years for fruit preparations, per the fructus monograph. Not because harm was demonstrated, but because data were absent.
• Broken skin, the eye area and mucous membranes for topical application of the oil, which the aetheroleum monograph carries as a warning rather than a formal contraindication.

Use Caution

• Liver disease, cholangitis, achlorhydria, gallstones and biliary tract disorders. Both EMA monographs list these, the same cautionary block applied across carminative volatile oils.
• Pregnancy and lactation. Safety has not been established and the monographs do not recommend use.
• Gastroesophageal reflux, where the peppermint component relaxes the lower esophageal sphincter. A peppermint problem rather than a caraway problem, and enteric coating largely solves it. May 2000 reported no eructation with peppermint taste from the coated capsule.
• Anyone already on a proton pump inhibitor or prokinetic. Unstudied, though the COLM-SST trial allowed concomitant dyspepsia medication throughout.

Critical Safety Point

Undiluted caraway essential oil is not an oral consumer product. The EMA oral ceiling is 0.3 mL per day in 1 to 3 doses, about 6 to 9 drops across an entire day, restricted to adults 18 and over. Several drops swallowed at once from a retail bottle is a different exposure from a dispersed, enteric-coated 50 mg dose, and that bottle carries no dosing instructions to tell you so.

Recommended Dosages

Whole fruit as tea or infusion

0.5 to 2 g of crushed fruit in 150 mL of boiling water, 1 to 3 times daily. Daily total 1.5 to 6 g. This is the EMA and Commission E dose, the one with the longest traditional record.

Whole or ground fruit as food or capsule

Health Canada’s 2025 monograph permits 0.3 to 15 g per day of dried seed for adults 18 and over, a wide window reflecting culinary as well as medicinal use. Practically, 1 to 6 g per day is the realistic range.

Essential oil, oral

0.15 to 0.3 mL daily in 1 to 3 doses, adults only. At a relative density of 0.905 that is roughly 136 to 271 mg per day. Health Canada writes the same idea as 18 to 600 microliters per day.

Essential oil, topical

2 percent in a semi-solid preparation once daily to the abdomen, permitted for all ages under the EMA monograph. The German poultice tradition Lauche tested is a stronger version of the same idea.

Fixed combination with peppermint oil, the evidence-bearing dose

One enteric-coated capsule of 90 mg peppermint oil and 50 mg caraway oil, twice daily. Daily total 180 mg and 100 mg. Every placebo-controlled efficacy number in this issue comes from this dose or a direct equivalent.

Duodenal-release caraway plus L-menthol

2 capsules of 25 mg caraway oil and 20.75 mg L-menthol, twice daily. Daily total 100 mg caraway oil and 83 mg L-menthol, the regimen Chey used in 95 patients in 2019.

Duration

The EMA sets a hard 2-week review point: if symptoms persist past 2 weeks, see a clinician. Trial durations run 4 weeks for the placebo-controlled dyspepsia studies, 8 weeks for the 126-patient 2026 phase IV study and 90 days for the extract obesity trial. There is no long-term safety dataset beyond 36 months of COLM-SST surveillance across an estimated 1 million users.

Timing & Administration

Take it with or just before meals. The mechanism is local smooth muscle relaxation in the stomach and duodenum, so the oil needs to be present when the meal is.

For the enteric-coated combination, swallow whole with water, never chewed or opened. Breaking the coat defeats the formulation and reintroduces the reflux it was designed to prevent. Mascher’s crossover data quantify it: intact enteric capsules put carvone peak at 2.5 hours against 1.3 hours for immediate release.

For COLM-SST, the outcomes survey found 56.2 percent of 600 respondents took it before meals and 86.4 percent reported relief within 2 hours.

For tea, crush the fruit before infusing, because whole caraway extracts poorly with the vittae sealed. Steep covered for 10 to 15 minutes, since an uncovered cup vents the carvone you are trying to drink.

For the topical preparation, apply to the abdomen once daily. Lauche’s protocol used a hot poultice held in place for a session, daily for 3 weeks.

Avoid dosing at bedtime if reflux is part of your picture.

Timeline of Effects

Within 2 hours. The COLM-SST survey put 86.4 percent of 600 respondents at relief inside 2 hours. Chey’s trial found a significant reduction in postprandial distress symptoms at 24 hours, p = 0.039, with epigastric pain not significant at p = 0.074.

Days 1 to 7. Expect partial, meal-linked relief. Rich 2017 showed superiority over placebo at 2 weeks as well as at 4, both at p < 0.001.

Weeks 2 to 4. Where the primary endpoints sit. May 2000 measured change between day 1 and day 29 and found 40 percent pain reduction against 22 percent on placebo, with 67 percent of the active group much or very much improved against 21 percent. May 1996 found 63.2 percent pain-free at 4 weeks.

Weeks 4 to 8. The 2026 phase IV study ran 126 patients for 8 weeks with standardized effect sizes of 0.83 to 1.05 from baseline. It was single-arm and manufacturer-funded, so treat those as descriptive.

If nothing has changed by week 2, stop and get evaluated. That is the monograph instruction and it is a good one.

Benefits of Taking Caraway

Functional dyspepsia symptom relief. The strongest claim in the file, and it belongs to the combination. Across 5 randomized trials and 580 patients, the peppermint plus caraway capsule beat placebo on pain and global improvement and matched cisapride at 3 x 10 mg daily in a 118-patient equivalence study. The 2023 meta-analysis of 3 placebo-controlled trials in 249 patients reported a standardized mean difference of 0.80 for pain, 95 percent CI 0.39 to 1.21, and a risk ratio of 2.65 for global improvement, 95 percent CI 1.81 to 3.87.

Bloating and flatulence. The traditional-use indication both EMA monographs grant, and what most people buy caraway for. The evidence is traditional rather than trial-based.

Smooth muscle antispasmodic activity. Micklefield’s intraduodenal manometry showed 50 mg of caraway oil significantly reducing duodenal contraction amplitudes during phases I and II of the migrating motor complex, isolated from peppermint and from the carrier.

Irritable bowel syndrome, topically. Lauche’s crossover trial gave adequate relief rates of 51.8 percent for caraway oil poultices against 23.5 and 25.8 percent for hot and cold olive oil controls in 48 patients.

Tolerability. An observational dataset of 2,103 patients recorded 8 adverse events in 6 patients, 0.3 percent.

Potential Negatives & Side Effects

What actually gets reported

• Eructation with a mint taste, reflux and heartburn, all from the peppermint component. Enteric coating largely eliminates them, and May 2000 reported no cases with the coated capsule.
• Mild gastrointestinal complaints. The COLM-SST safety analysis listed dyspepsia at 22 reports, diarrhea at 13 and nausea at 11 across an estimated 1 million users.
• Allergic reactions in Apiaceae-sensitized people, with skin, oral and respiratory presentations all in the spice allergy literature.
• Contact reactions from topical use of undiluted oil.

The trial numbers in context

May 2000 recorded adverse events in 6 of 96 patients, 5 active and 1 placebo, judged unrelated or attributable to the underlying disease. May 1996 recorded 7 events across 39 evaluable patients with causal attribution in 1 active and 1 placebo case. Madisch 1999 recorded 12 events in the 60-patient combination group against 14 in the 58-patient cisapride group. None of these are large safety datasets.

Regulatory signal

The EMA periodic review covering 2020 to 2025 identified 3 serious EudraVigilance case reports. Two involved combination products and could not be attributed to caraway as a single herbal substance. One involved a neonate given caraway suppositories who developed diarrhea. None triggered a revision.

Deficiency Symptoms

Caraway is not an essential nutrient. Humans do not require carvone, limonene or any other caraway constituent, no dietary reference intake exists, and no deficiency state can occur. Nobody has ever presented to a clinic with low caraway.

What caraway addresses

A functional complaint, not a nutritional gap. Postprandial bloating, fullness and epigastric discomfort without structural disease. Those symptoms have many causes, and a carminative volatile oil treats the sensation rather than the cause.

Bottom line

Stop taking caraway and nothing is lost except whatever symptomatic relief you were getting. There is no washout deficit, no rebound and no reason to taper.

Toxicity Symptoms

At high intake

JECFA set an ADI of 0 to 1 mg per kg body weight per day for (+)-carvone, from a no-observed-adverse-effect level of 93 mg per kg per day in a 3-month rat study. For a 70 kg adult that is 70 mg of carvone per day. Note the collision: one teaspoon of caraway seed holds roughly 32 to 96 mg of carvone, and the EMA oral oil dose of 0.15 to 0.3 mL supplies roughly 68 to 176 mg per day. That ADI covers carvone added as a flavoring agent and is not a hazard threshold for a spice, but monograph doses do sit above a number a food additive committee treated as a lifetime ceiling. JECFA calculated margins of safety above 500 for the (+)-isomer against per capita flavoring intake.

Signs to reduce or stop

• Persistent nausea, burning epigastric pain or vomiting after dosing
• Diarrhea that begins with the product and resolves without it
• Any skin or mucosal reaction after topical application
• Hives, lip or tongue swelling, wheezing or throat tightness, which warrant immediate medical attention rather than dose reduction
• Symptoms worsening rather than improving over the first 14 days

General note

No human poisoning case series exists for caraway at culinary or monograph doses. The realistic hazards are allergy, mucosal irritation from undiluted oil, and accidental ingestion of retail essential oil by a child. Store essential oil bottles the way you store medication.

How Caraway Works

The molecule

Carvone is a lipophilic monoterpene ketone with a molecular weight of 150.2. Limonene, the second constituent, is a monoterpene hydrocarbon that acts largely as a carrier.

Smooth muscle relaxation

The primary mechanism is direct relaxation of gastrointestinal smooth muscle. A 2026 evidence-graded review of carvone covering 108 sources found the spasmolytic effect across multiple preparations, with both enantiomers relaxing carbachol-induced contraction in guinea pig trachea and rat aorta at comparable potency, and attributed it to calcium channel blockade, potassium channel activation, or both. R-carvone blocks L-type calcium channels in cardiac tissue in patch-clamp work. That review graded only 2 molecular targets, the aryl hydrocarbon receptor and GABA-A, at its highest evidence tier.

Where it acts

Locally. Micklefield’s intraduodenal study is the cleanest human demonstration: 50 mg of caraway oil delivered straight to the duodenum reduced contraction amplitude, and the effect substantially exceeded both the galenic carrier and the hydrophobic auxiliary material. Systemic exposure is trivial by comparison, with carvone peaking at 14 ng/mL after a 100 mg dose.

Why it does not empty the stomach faster

Two independent studies, one in 12 volunteers and one in 32, found no change in gastric emptying. A muscle relaxant would not be expected to speed transit. The relief comes from reduced contraction amplitude, and probably from reduced visceral sensitivity, rather than from moving food along.

What we still cannot say

Whether carvone or limonene carries the effect. Whether the combination is additive or synergistic. Whether the 50 mg caraway component contributes more than a few percentage points to the 90 mg peppermint effect. No dose-ranging study of caraway oil in humans has been published.

Synergistic Supplements

Peppermint oil, the only combination with real evidence

This is the entire commercial basis of the category. 90 mg peppermint oil plus 50 mg caraway oil, or 25 mg caraway oil plus 20.75 mg L-menthol in the duodenal-release version. Micklefield’s manometry work showed both components acting, with peppermint reducing contraction frequency and duration during phase III of the migrating motor complex and caraway reducing contraction amplitudes during phases I and II. They hit different aspects of the same motility pattern.

Multi-herb preparations that include caraway

STW 5, sold as Iberogast, contains 9 herbal extracts including caraway fruit alongside bitter candytuft, chamomile, peppermint, licorice, lemon balm, angelica root, celandine and milk thistle. The 6-herb STW 5-II drops three but keeps caraway. Madisch’s 2004 trial in 120 patients reported 43.3 percent complete symptom relief on active treatment against 3.3 percent on placebo at 8 weeks, which says nothing about caraway specifically. Iberogast also carries a liver toxicity warning that German authorities ordered in a risk assessment procedure opened in 2008 and that Bayer implemented in 2018, after a fatal liver failure case attributed to celandine.

Plausible but unstudied pairings

• Fennel and anise, the other carminative Apiaceae, on shared traditional grounds and no trial data
• Ginger, where the evidence base is separate and does not overlap with caraway
• Artichoke leaf, used in European dyspepsia practice with its own trial record

What not to expect

No evidence that caraway improves absorption of any nutrient, no probiotic interaction data, and nothing supporting a caraway plus digestive enzyme combination beyond marketing.

Interactions & What NOT to Take

Documented drug interactions

None established in humans, which is a statement about missing interaction studies rather than a clean bill.

Theoretical concerns worth respecting

• Prokinetics. Madisch 1999 compared the combination against cisapride rather than adding to it, and the two push contractility in opposite directions. Pairing an antispasmodic with a prokinetic is incoherent.
• Antacids and proton pump inhibitors. Raising gastric pH can degrade some enteric coatings early. The COLM-SST trial permitted concomitant and rescue medication after 48 hours and reported no formulation problems, so this stays theoretical.
• Antidiabetic agents. Rodent hypoglycemia data exist for caraway extracts with no human confirmation, and the 12-week, 70-woman safety study of a 30 mL daily aqueous extract found no significant changes across a 25-item blood chemistry panel.
• CYP-mediated metabolism. Caraway extract suppresses dioxin-induced CYP1A1 expression in rat hepatoma cells. Relevance to human drug metabolism at spice doses is unestablished.

What not to combine

• Undiluted caraway essential oil with any other undiluted essential oil taken orally. Total monoterpene load is the issue, not caraway specifically.
• Caraway with any product that has not identified its species. Read the next section.

Before surgery

No specific data. The standard herbal guidance of stopping 1 to 2 weeks before elective procedures applies by default, not by evidence.

Quality, Testing & Adulteration

The species problem

Several distinct plants sell under overlapping names, and only one is caraway.

• Carum carvi L., Apiaceae, true caraway. Carvone-dominant.
• Cuminum cyminum L., Apiaceae, cumin. Cuminaldehyde-dominant, almost no carvone, and visually similar enough to be confused in kitchens and supply chains. The English words caraway and cumin share a Latin and Greek root, which is why the confusion has lasted centuries.
• Nigella sativa L., Ranunculaceae, sold as black caraway, black cumin, black seed and kalonji. A different family entirely, with thymoquinone rather than carvone as its marker. Nothing in the caraway evidence base applies to it.

Add a fourth. Elwendia persica (Boiss.) Pimenov and Kljuykov, formerly Bunium persicum, is an Apiaceae species sold as black caraway, black cumin, kala jeera and shahi jeera. It has its own chemistry and is routinely swapped for Nigella sativa and for cumin.

If a label says black caraway or black cumin without a Latin binomial, you cannot tell which plant is in the bottle.

Authentication tests that exist and work

• Optical rotation. Authentic caraway oil runs +67 to +80 degrees at 20 degrees Celsius because S-(+)-carvone is dextrorotatory. Spearmint-derived R-(-)-carvone is levorotatory. Blending spearmint carvone into caraway oil drags the rotation toward zero, and the test takes minutes on a polarimeter.
• Chiral gas chromatography. Ravid published enantiomeric separation of carvone in caraway, dill and spearmint oils in 1992. It settles the question and is standard in flavor authentication labs.
• Relative density at 0.900 to 0.920 and refractive index at 1.484 to 1.490 at 20 degrees Celsius per ISO 8896, alongside a full GC-MS profile showing carvone at 50.0 to 63.0 percent and limonene at 33.0 to 45.0 percent. The European Pharmacopoeia limits are carvone at 50 to 65 percent and limonene at 30 to 45 percent.

Adulteration routes

• Synthetic carvone, racemic unless deliberately resolved and therefore failing optical rotation.
• Spearmint oil, the cheapest natural carvone source, which fails both optical rotation and chiral GC.
• D-limonene from citrus processing, a bulk industrial by-product that inflates yield and depresses the carvone percentage.
• Dill oil, which also contains S-(+)-carvone and so passes both the rotation test and chiral GC. Full profile comparison catches it.
• Exhausted fruit, caraway already steam-distilled and sold on as whole spice or ground powder. It looks identical and contains almost no oil.

What to require from a supplier

A GC-MS profile with the carvone percentage stated, an optical rotation figure, a species binomial and a country of origin. For whole-fruit capsules, a volatile oil determination in mL per kg. Most sellers provide none of these, and a certificate showing only heavy metals and microbial counts tells you the material is clean without telling you what it is.

Special Considerations

Infant colic and gripe water

Gripe water traces to William Woodward, an English pharmacist, in 1851. The original contained about 3.6 percent alcohol with sodium bicarbonate, sugar and dill oil, not caraway. Alcohol came out of the British formulation in 1992, and in 1993 the FDA ordered automatic detention of Woodward’s Gripe Water shipments into the United States as an unapproved drug. Current US gripe waters are dietary supplements and some do include caraway. Colic-Ease lists caraway seed oil among 5 essential oils alongside dill, cinnamon, clove and cardamom.

Kingston Pharma voluntarily recalled all lots of DG Baby Gripe Water in 2019 over an undissolved citrus flavonoid that posed a choking hazard, and the FDA has warned consumers about Cryptosporidium contamination in a gripe water product.

There is no randomized trial of caraway for infant colic. The EMA restricts oral caraway oil to adults 18 and over. Health Canada permits 0.06 to 1 g per day of seed and 0.26 to 130 microliters per day of oil in infants 6 to 12 months, a permissive monograph rather than a positive evidence base, and it excludes infants under 6 months.

The carvone smell trick

The carvone in caraway and the carvone in spearmint differ at a single stereocenter and smell like different plants. This is the textbook demonstration that olfactory receptors are themselves chiral, and the reason a caraway product that smells minty is one you should return.

Athletes

Caraway contains nothing on any prohibited list. The aqueous extract obesity trial recruited aerobic-trained women and reported no adverse events over 90 days at 30 mL per day.

Kidney and liver disease

No dosing adjustments have been studied. The EMA cautions against use in liver disease and biliary disorders, which is reason enough to avoid rather than adjust.

Research Status & Evidence Quality

Strong Evidence For

• Nothing, for caraway as a single ingredient.
• For the fixed peppermint oil plus caraway oil combination at 90 mg plus 50 mg twice daily, functional dyspepsia symptom relief over 4 weeks. Five randomized trials, 580 patients, all at maximum Jadad scores. Pain effect at a standardized mean difference of 0.80 across 3 trials and 249 patients, global improvement risk ratio 2.65, and non-inferiority to cisapride at 3 x 10 mg daily in 118 patients.

Moderate Evidence For

• Caraway oil acting locally on gastroduodenal smooth muscle. Micklefield’s intraduodenal manometry isolated the 50 mg caraway component and showed an effect separate from peppermint and from the carrier.
• Tolerability. 2,103 patients observationally with 8 events in 6, plus 36 months of surveillance across roughly 1 million COLM-SST users at 0.0187 percent and no serious events.
• Caraway oil poultices for irritable bowel syndrome. One randomized crossover trial, 48 patients, IBS-SSS difference -38.4 at p = 0.033 against unheated olive oil but only -24.3 at p = 0.139 against hot olive oil, with the authors attributing the benefit possibly to the heat rather than the caraway. Topical, open-label, single center.

Emerging / Preliminary Evidence For

• Weight and body composition. One trial, 70 overweight and obese aerobic-trained women, 30 mL per day of caraway aqueous extract for 90 days, with significant reductions in weight, BMI, body fat percentage and waist-to-hip ratio, and no change in lipids or blood pressure. Registered as NCT01833377, reported across three papers from one group, never independently replicated.
• Rapid relief from duodenal-release caraway plus L-menthol. Chey 2019, 95 patients, significant at 24 hours for postprandial distress syndrome at p = 0.039, but no significant difference in Global Overall Symptom scores at 2 or 4 weeks.

Research Limitations

• No oral caraway-monotherapy randomized trial in functional dyspepsia exists. A PubMed search restricted to clinical trial publication types returns 23 records with caraway or Carum carvi in the title or abstract, and not one tests oral caraway alone against placebo for a digestive endpoint.
• No dose-ranging study of caraway oil in humans. The 50 mg and 100 mg figures come from a formulation decision made in the 1990s, not a dose-response experiment.
• Trials are small. The largest placebo-controlled dyspepsia trial enrolled 114 patients, and the 2026 phase IV study with 126 patients had no control group.
• Sponsor concentration is heavy. One manufacturer’s funded studies dominate the Menthacarin literature, with employees among the authors, and another dominates the COLM-SST literature.
• The 2026 evidence-graded review of carvone across 108 sources found high-tier support for only 2 molecular targets.
• Both EMA monographs are traditional-use. The agency reviewed the evidence in 2015, declined to grant well-established use, and the 2020 to 2025 review changed nothing.

Summary & Key Takeaways

Caraway is a good spice with a borrowed clinical record. The functional dyspepsia evidence that sells caraway capsules came from a fixed combination of 90 mg peppermint oil and 50 mg caraway oil in an enteric-coated capsule, dosed twice daily, tested in 5 randomized trials across 580 patients. The caraway-alone capsule on the shelf contains one of those two oils, usually as unstandardized ground fruit rather than distilled oil, with no enteric protection and no carvone specification, sold against results it had no part in producing. The borrowing here is not across species, the usual failure in this category. It runs from a combination to a single component, and it is harder to see because the species on the label is genuinely the species in the bottle.

Bottom Line

If you want the effect the trials found, buy the combination the trials tested. If you want caraway itself, the honest version is 0.5 to 2 g of crushed fruit in 150 mL of hot water after meals, 1 to 3 times daily, for the bloating and flatulence indication the EMA actually granted on 7 July 2015. Give it 2 weeks. If nothing changes, the monograph tells you to see a clinician, and that instruction is worth more than the product.

Key Safety Points

• Oral essential oil is for adults 18 and over, capped at 0.3 mL per day. Fruit preparations are not recommended under 12 years.
• Avoid in Apiaceae allergy, which cross-reacts with celery, fennel, anise, coriander, dill, mugwort and birch.
• Avoid in liver disease, cholangitis, achlorhydria, gallstones and biliary disorders per both EMA monographs.
• Not recommended in pregnancy or lactation, on absent data rather than demonstrated harm.
• The 2-week review point is not a formality. Persistent dyspepsia needs a diagnosis.

Special Note

Two plants sell as black caraway or black cumin, and neither is Carum carvi. Nigella sativa is a different botanical family and Elwendia persica a different genus. Cuminum cyminum, plain cumin, is a third confusable species with a different marker compound. Buy on the binomial, confirm on the optical rotation, and treat any caraway product that smells of spearmint as the adulterated material it almost certainly is.